Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 72.03 Million AUD | -3.89% |
| 2023 | 74.94 Million AUD | -10.11% |
| 2022 | 83.38 Million AUD | 249260.88% |
| 2021 | 33.43 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 63.29 Million AUD | -24.09% |
| 2024 Q2 | 63.29 Million AUD | 0.0% |
| 2024 Q3 | 72.03 Million AUD | 13.81% |
| 2024 Q4 | 72.03 Million AUD | 0.0% |
| 2024 FY | 72.03 Million AUD | -3.89% |
| 2023 Q4 | 83.38 Million AUD | 11.25% |
| 2023 FY | 74.94 Million AUD | -10.11% |
| 2023 Q3 | 74.94 Million AUD | -11.9% |
| 2023 Q2 | 85.06 Million AUD | 0.0% |
| 2023 Q1 | 85.06 Million AUD | 2.02% |
| 2022 Q4 | 83.38 Million AUD | 0.0% |
| 2022 Q3 | 83.38 Million AUD | -8.42% |
| 2022 Q2 | 91.04 Million AUD | 0.0% |
| 2022 Q1 | 91.04 Million AUD | 0.0% |
| 2022 FY | 83.38 Million AUD | 249260.88% |
| 2021 FY | 33.43 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -181.921% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -4209.884% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -1289.746% |
| Biome Australia Limited | 8.27 Million AUD | -770.342% |
| Patrys Limited | 4.16 Million AUD | -1630.985% |
| Orthocell Limited | 26.61 Million AUD | -170.659% |
| Imugene Limited | 151.39 Million AUD | 52.419% |
| Noxopharm Limited | 6.78 Million AUD | -961.894% |
| PYC Therapeutics Limited | 91.23 Million AUD | 21.046% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -371.653% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -253.243% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -562.396% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -758.773% |
| CSL Limited | 56.93 Billion AUD | 99.873% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -442.251% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -2179.927% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 68.832% |
| Starpharma Holdings Limited | 36.81 Million AUD | -95.676% |
| Nanollose Limited | 241.95 Thousand AUD | -29673.113% |
| Memphasys Limited | 12.43 Million AUD | -479.529% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -1077.055% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -1225.203% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -385.253% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 35.948% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -2709.014% |
| Race Oncology Limited | 20.22 Million AUD | -256.112% |
| Nyrada Inc. | 5.9 Million AUD | -1119.454% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 81.914% |
| Dimerix Limited | 32.07 Million AUD | -124.562% |
| PharmAust Limited | 11.12 Million AUD | -547.526% |
| Immutep Limited | 147.44 Million AUD | 51.145% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 53.413% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -274.726% |
| BTC Health Limited | 5.14 Million AUD | -1299.088% |
| Acrux Limited | 8.96 Million AUD | -703.708% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 70.95% |
| Biotron Limited | 493.47 Thousand AUD | -14497.74% |
| Tissue Repair Ltd | 19.38 Million AUD | -271.521% |
| AdAlta Limited | 5.57 Million AUD | -1192.595% |
| Hexima Limited | 2.26 Million AUD | -3074.8% |
| AnteoTech Limited | 9.38 Million AUD | -667.881% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -162.998% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -1030.937% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -884.196% |
| Actinogen Medical Limited | 21.31 Million AUD | -238.01% |
| Immuron Limited | 15.54 Million AUD | -363.257% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -339.848% |